Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs.

CSL Vifor offers a communication campaign to answer EU allegations it disparaged a rival iron deficiency treatment from Pharmacosmos.

The government will allocate the payment to affordable homes programmes across all four nations, including giving funding ...

Here's why these Australian stocks could be among the best to buy and hold forever right now. Let's dig deeper into ...

The developer funds will be used to build "hundreds" of new affordable houses across England, Scotland, Wales and Northern ...

ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.

CSL will consolidate its R&D teams around six sites located in biotech hubs as the company looks to boost external ...

India Open To $23 Billion Tariff Cut, Including Agri, Pharma,To Avert Trade Dispute.

Read about LTR Pharma Ltd (LTP:XASX) stock and today's latest news and financial updates.

The parenteral formula market, as projected by Future Market Insights, is expected to reach USD 12.27 billion by 2035. Demand is rising. That should be good news. But behind the numbers is a ...